Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes-Reference-Cited by-同舟云学术

Timing of Abatacept Before Elective Arthroplasty and Risk of Postoperative Outcomes

Published:2019-07-11 Issue:9 Volume:71 Page:1224-1233
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

George Michael D.¹^ORCID,Baker Joshua F.²^ORCID,Winthrop Kevin³,Alemao Evo⁴^ORCID,Chen Lang⁵,Connolly Sean⁶,Hsu Jesse Y.¹,Simon Teresa A.⁴^ORCID,Wu Qufei¹,Xie Fenglong⁵,Yang Shuo⁵,Curtis Jeffrey R.⁵^ORCID

Affiliation:

1. University of Pennsylvania Perelman School of Medicine Philadelphia

2. Philadelphia Veterans Affairs Medical Center Philadelphia Pennyslvania

3. Oregon Health & Science University Portland

4. Bristol‐Myers Squibb Princeton New Jersey

5. University of Alabama at Birmingham

6. Bristol‐Myers Squibb Plainsboro New Jersey

Funder

Bristol-Myers Squibb

National Institute of Arthritis and Musculoskeletal and Skin Diseases

Rheumatology Research Foundation

Patient-Centered Outcomes Research Institute

Publisher

Wiley

Subject

Rheumatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr.23843

Reference40 articles.

1. Orthopedic Surgery Among Patients with Rheumatoid Arthritis 1980–2007: A Population-based Study Focused on Surgery Rates, Sex, and Mortality

2. CDC Definitions of Nosocomial Surgical Site Infections, 1992: A Modification of CDC Definitions of Surgical Wound Infections

3. Increased Risk of Complications Following Total Joint Arthroplasty in Patients With Rheumatoid Arthritis

4. Perioperative outcomes in patients with rheumatoid versus osteoarthritis for total hip arthroplasty: a population‐based study;Stundner O;Clin Exp Rheumatol,2013

5. 2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Full Guidelines—From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritis;Journal of the American Academy of Dermatology;2024-08

2. Newer Immunosuppressants for Rheumatologic Disease;Rheumatic Disease Clinics of North America;2024-08

3. Newer Immunosuppressants for Rheumatologic Disease;Anesthesiology Clinics;2024-03

4. Updated American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty 2022;Rheumatology Science and Practice;2023-06-28

5. Australian recommendations on perioperative use of disease‐modifying anti‐rheumatic drugs in people with inflammatory arthritis undergoing elective surgery;Internal Medicine Journal;2023-05-22